Neoadjuvant Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer in a Single High-Volume Center

Zanoni, A.; Verlato, G.; Giacopuzzi, S.; Weindelmayer, J.; Casella, F.; Pasini, F.; Zhao, E.; Manzoni, G.
June 2013
Annals of Surgical Oncology: An Oncology Journal for Surgeons;Jun2013, Vol. 20 Issue 6, p1993
Academic Journal
No abstract available.


Related Articles

  • Early distant relapse after optimal local control in locally advanced rectal cancer. Gallego-Plazas, Javier; Menarguez-Pina, Francisco; Martinez-Banaclocha, Natividad; Pons-Sanz, Vanesa; Mingol-Navarro, Fernando; Ruiz-Macia, Jose A.; Macia-Escalante, Sonia // International Seminars in Surgical Oncology;2008, Vol. 5, Special section p1 

    We present a case of locally advanced rectal cancer with initial optimal local control after neoadjuvant concurrent chemoradiotherapy followed by surgery; early liver recurrence then occurred and was treated again with curative intent with neoadjuvant combination chemotherapy followed by liver...

  • Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study. Velenik, Vaneja; Ocvirk, Janja; Music, Maja; Bracko, Matej; Anderluh, Franc; Oblak, Irena; Edhemovic, Ibrahim; Brecelj, Erik; Kropivnik, Mateja; Omejc, Mirko // Radiation Oncology;2011, Vol. 6 Issue 1, p105 

    Background: Preoperative capecitabine-based chemoradiation is a standard treatment for locally advanced rectal cancer (LARC). Here, we explored the safety and efficacy of the addition of bevacizumab to capecitabine and concurrent radiotherapy for LARC.Methods: Patients...

  • Lokal Ä°leri Evre Özefagus Kanserinde Kemoradyoterapi Deneyimimiz. ALSAN ÇETİN, İlknur; ÖNCÜ YUMUK, P. Fulden; ATASOY, Beste M.; DANE, Faysal; Başak ÇAĞLAR, Hale; İBRAHİMOV, Roman; Fevzi BATIREL, Hasan; ABACIOĞLU, Ufuk // Marmara Medical Journal;2012, Vol. 25 Issue 2, p74 

    Objective: In this study, we report our neoadjuvant/definitive chemoradiotherapy (CRT) experience in locally advanced esophageal cancer patients. Patients and Methods: A total of 15 patients were retrospectively evaluated. Histological diagnosis were as follows: squamous cell 10, adenocarcinoma...

  • Recent advances in multidisciplinary approach for rectal cancer. Oki, Eiji; Ando, Koji; Kasagi, Yuta; Zaitsu, Yoko; Sugiyama, Masahiko; Nakashima, Yuichiro; Sonoda, Hideto; Ohgaki, Kippei; Saeki, Hiroshi; Maehara, Yoshihiko // International Journal of Clinical Oncology;Aug2015, Vol. 20 Issue 4, p641 

    Surgery is a major treatment option for rectal cancer, and total mesorectal excision has been demonstrated to be advantageous in terms of oncological outcome and thus has been the standard surgical approach. Radiotherapy before or after radical surgery is the optimal treatment to control local...

  • Chemoradiotherapy followed by surgery versus surgery alone in esophageal cancer patients: is it time for additional evidence? Cafarotti, Stefano; Cesario, Alfredo; Porziella, Venanzio; Margaritora, Stefano; Granone, Pierluigi // World Journal of Surgical Oncology;2011, Vol. 9 Issue 1, p41 

    Recent efforts to improve survival in patients with locally advanced esophageal carcinoma have combined both systemic and local therapy. However, the role of neoadjuvant chemoradiotherapy in technically operable IIa-III esophageal carcinoma is still unresolved.n

  • Concurrent chemoradiotherapy for locally advanced breast cancer—time for a new paradigm? Mandilaras, V.; Bouganim, N.; Spayne, J.; Dent, R.; Arnaout, A.; Boileau, J. F.; Brackstone, M.; Meterissian, S.; Clemons, M. // Current Oncology;Feb2015, Vol. 22 Issue 1, p25 

    Background In cases of locally advanced breast cancer (LABC), preoperative ("neoadjuvant") therapy was traditionally reserved to render the patient operable. More recently, neoadjuvant therapy, particularly chemotherapy, is being used in patients with operable disease to increase the opportunity...

  • Neoadjuvant versus adjuvant treatment: which one is better for resectable esophageal squamous cell carcinoma? Yaping Xu; Xinmin Yu; Qixun Chen; Weimin Mao // World Journal of Surgical Oncology;2012, Vol. 10 Issue 1, p173 

    Esophageal cancer is the eighth most common cancer worldwide, and especially in some areas of China is the fourth most common cause of death and is of squamous cell carcinoma (SCC) histology in >90% of cases. Surgery alone was the mainstay of therapeutic intervention in the past, but high rates...

  • Prospective Feasibility Study to Evaluate Neoadjuvant-synchronous S-1 + RT for Locally Advanced Rectal Cancer: A Multicenter Phase II Trial (UMIN ID: 03396). Inomata, Masafumi; Akagi, Tomonori; Nakajima, Kentaro; Etoh, Tsuyoshi; Shiraishi, Norio; Tahara, Koichiro; Matsumoto, Toshifumi; Kinoshita, Tadahiko; Fujii, Kyuzo; Shiromizu, Akio; Kubo, Nobuhiro; Kitano, Seigo // Japanese Journal of Clinical Oncology;Mar2013, Vol. 43 Issue 3, p321 

    In Western countries, the standard treatment for locally advanced rectal cancer is preoperative chemoradiotherapy followed by total mesorectal excision. However, in Japan, the treatment results without preoperative chemoradiotherapy are by no means inferior; therefore, extrapolation of the...

  • Current definition of locally advanced breast cancer. Garg, Pankaj Kumar; Prakash, Gaurav // Current Oncology;Oct2015, Vol. 22 Issue 5, pe409 

    A letter to the editor is presented in response to the article "Concurrent chemoradiotherapy for locally advanced breast cancer-time for a new paradigm?" by V. Mandilaras and colleagues in the 2015 issue.

  • Response to: "Current definition of locally advanced breast cancer". Brackstone, Muriel // Current Oncology;Oct2015, Vol. 22 Issue 5, pe411 

    A response from the authors of the article "Concurrent chemoradiotherapy for locally advanced breast cancer-time for a new paradigm?" in the 2015 issue is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics